Pentacel

bexsero

Vaccines

Bexsero, Shingrix to pass $1B sales mark by 2022: report

Analysts with Evaluate predict GlaxoSmithKline's Bexsero and Shingrix will quickly grow sales in the coming years.

Eric Sagonowsky Jun 20, 2017 4:20pm

Sanofis headquarters in Paris

Sanofi's vaccines grow 13.2% despite dengue woes

May 2, 2017 9:21am

Sanofi Pasteur

Sanofi Pasteur rolls out DTaP-IPV vaccine Quadracel

Jan 31, 2017 3:12pm